SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 3,913.63 |
Enterprise Value ($M) | 6,972.93 |
Book Value ($M) | 4,319.40 |
Book Value / Share | 31.65 |
Price / Book | 0.91 |
NCAV ($M) | -2,846.40 |
NCAV / Share | -20.86 |
Price / NCAV | -1.37 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.02 |
Return on Assets (ROA) | -0.02 |
Return on Equity (ROE) | -0.04 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 1.34 |
Current Ratio | 2.38 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 2,481.90 |
Assets | 9,647.70 |
Liabilities | 5,328.30 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 4,373.40 |
Operating Income | 314.60 |
Net Income | -171.80 |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 362.90 |
Cash from Investing | 78.80 |
Cash from Financing | -611.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G | Price T Rowe Associates Inc /md/ | 5.80 | 9,919.21 | |
13G | State Street Corp | 5.10 | ||
13G | Dimensional Fund Advisors Lp | 5.10 | ||
13G | Barrow Hanley Mewhinney & Strauss Llc | |||
13G/A | Vanguard Group Inc | 11.07 | 2.77 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
208,951 | 1,418,674 | 14.73 | |
307,235 | 1,883,513 | 16.31 | |
210,554 | 1,152,475 | 18.27 | |
527,012 | 2,707,465 | 19.47 | |
(click for more detail) |
Similar Companies | |
---|---|
OGN – Organon & Co. | PBH – Prestige Consumer Healthcare Inc. |
PFE – Pfizer Inc. | QGEN – Qiagen N.V. |
RCUS – Arcus Biosciences, Inc. |
Financial data and stock pages provided by
Fintel.io